RELMADA THERAPEUTICS, INC. — Major Shareholding Notification 2021

Feb 16, 2021

SC 13G/A 1 tm216523d6_sc13ga.htm SC 13G/A

Field: Rule-Page

Field: /Rule-Page

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934 (Amendment No. 1)*

Relmada Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

75955J402

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨	Rule 13d-1(b)
x	Rule 13d-1(c)
¨	Rule 13d-1(d)

• The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons Venrock Healthcare Capital Partners II, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) PN

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

2

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons VHCP Co-Investment Holdings II, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) OO

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 3; Value: 2

3

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons Venrock Healthcare Capital Partners III, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) PN

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 4; Value: 2

4

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons VHCP Co-Investment Holdings III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) OO

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 5; Value: 2

5

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons VHCP Management II, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) OO

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 6; Value: 2

6

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons VHCP Management III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) OO

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 7; Value: 2

7

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons Shah, Nimish
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned by Each Reporting Person With:	Sole Voting Power 0
6.	Shared Voting Power 668,440(2)
7.	Sole Dispositive Power 0
8.	Shared Dispositive Power 668,440(2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) IN

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 8; Value: 2

8

Field: /Page

CUSIP No. 75955J402 — 1.	Name of Reporting Persons Koh, Bong
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	x (1)
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned by Each Reporting Person With:		Sole Voting Power 0
	6.	Shared Voting Power 668,440(2)
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 668,440(2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 668,440(2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 4.1%(3)
12.	Type of Reporting Person (See Instructions) IN

Field: Rule-Page

Field: /Rule-Page

(1)	Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2)	Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3)	This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

Field: Page; Sequence: 9; Value: 2

9

Field: /Page

CUSIP No. 75955J402

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III” and collectively with VHCP II LP, VHCP Co-Investment II, VHCP III LP, VHCP Co-Investment III and VHCP Management II, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of Common Stock of Relmada Therapeutics, Inc.

Item 1. — (a)	Name of Issuer Relmada Therapeutics, Inc.
(b)	Address of Issuer’s Principal Executive Offices 880 Third Avenue, 12 th Floor New York, NY 10022
Item 2.
(a)	Name of Person Filing Venrock Healthcare Capital Partners II, L.P. VHCP Co-Investment Holdings II, LLC Venrock Healthcare Capital Partners III, L.P. VHCP Co-Investment Holdings III, LLC VHCP Management II, LLC VHCP Management III, LLC Nimish Shah Bong Koh
(b)	Address of Principal Business Office or, if none, Residence
	New York Office:	Palo Alto Office:
	7 Bryant Park	3340 Hillview Avenue
	23rd Floor	Palo Alto, CA 94304
	New York, NY 10018
(c)	Citizenship All of the Venrock Entities were organized in Delaware. The
individuals are both United States citizens.
(d)	Title of Class of Securities Common Stock, par value $0.001 per share
(e)	CUSIP Number 75955J402

Field: Page; Sequence: 10; Value: 2

10

Field: /Page

CUSIP No. 75955J402

Item 3.	If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable
Item 4.	Ownership
	(a)	Amount Beneficially Owned as of December 31, 2020:
			Venrock Healthcare Capital Partners II, L.P.	668,440	(1)
			VHCP Co-Investment Holdings II, LLC	668,440	(1)
			Venrock Healthcare Capital Partners III, L.P.	668,440	(1)
			VHCP Co-Investment Holdings III, LLC	668,440	(1)
			VHCP Management II, LLC	668,440	(1)
			VHCP Management III, LLC	668,440	(1)
			Nimish Shah	668,440	(1)
			Bong Koh	668,440	(1)
	(b)	Percent of Class as of December 31, 2020:
			Venrock Healthcare Capital Partners II, L.P.	4.1	%
			VHCP Co-Investment Holdings II, LLC	4.1	%
			Venrock Healthcare Capital Partners III, L.P.	4.1	%
			VHCP Co-Investment Holdings III, LLC	4.1	%
			VHCP Management II, LLC	4.1	%
			VHCP Management III, LLC	4.1	%
			Nimish Shah	4.1	%
			Bong Koh	4.1	%
	(c)	Number of shares as to which the person has, as of December 31, 2020:
		(i)	Sole power to vote or to direct the vote
			Venrock Healthcare Capital Partners II, L.P.	0
			VHCP Co-Investment Holdings II, LLC	0
			Venrock Healthcare Capital Partners III, L.P.	0
			VHCP Co-Investment Holdings III, LLC	0
			VHCP Management II, LLC	0
			VHCP Management III, LLC	0
			Nimish Shah	0
			Bong Koh	0

Field: Page; Sequence: 11; Value: 2

11

Field: /Page

CUSIP No. 75955J402

(ii)	Shared power to vote or to direct the vote — Venrock Healthcare Capital Partners II, L.P.	668,440	(1)
	VHCP Co-Investment Holdings II, LLC	668,440	(1)
	Venrock Healthcare Capital Partners III, L.P.	668,440	(1)
	VHCP Co-Investment Holdings III, LLC	668,440	(1)
	VHCP Management II, LLC	668,440	(1)
	VHCP Management III, LLC	668,440	(1)
	Nimish Shah	668,440	(1)
	Bong Koh	668,440	(1)
(iii)	Sole power to dispose or to direct the disposition of
	Venrock Healthcare Capital Partners II, L.P.	0
	VHCP Co-Investment Holdings II, LLC	0
	Venrock Healthcare Capital Partners III, L.P.	0
	VHCP Co-Investment Holdings III, LLC	0
	VHCP Management II, LLC	0
	VHCP Management III, LLC	0
	Nimish Shah	0
	Bong Koh	0
(iv)	Shared power to dispose or to direct the disposition of
	Venrock Healthcare Capital Partners II, L.P.	668,440	(1)
	VHCP Co-Investment Holdings II, LLC	668,440	(1)
	Venrock Healthcare Capital Partners III, L.P.	668,440	(1)
	VHCP Co-Investment Holdings III, LLC	668,440	(1)
	VHCP Management II, LLC	668,440	(1)
	VHCP Management III, LLC	668,440	(1)
	Nimish Shah	668,440	(1)
	Bong Koh	668,440	(1)

Field: Rule-Page

Field: /Rule-Page

(1) These shares are owned directly as follows: 61,894 shares are owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares are owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares are owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares are owned by VHCP Co-Investment Holdings III, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. Messrs. Shah and Koh are the voting members of VHCP Management II, LLC and VHCP Management III, LLC.

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check
the following x .
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not Applicable
Item 8.	Identification and Classification of Members of the Group
Not Applicable
Item 9.	Notice of Dissolution of a Group
Not Applicable

Field: Page; Sequence: 12; Value: 2

12

Field: /Page

CUSIP No. 75955J402

ITEM 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 16, 2021

Venrock Healthcare Capital Partners II, L.P. — By:	VHCP Management II, LLC	By:	VHCP Management III, LLC
Its:	General Partner	Its:	General Partner
By:	/s/ David L. Stepp	By:	/s/ David L. Stepp
	Name:	David L. Stepp	Name:	David L. Stepp
	Its:	Authorized Signatory	Its:	Authorized Signatory
VHCP Co-Investment Holdings II, LLC		VHCP Co-Investment Holdings III, LLC
By:	VHCP Management II, LLC	By:	VHCP Management III, LLC
Its:	Manager	Its:	Manager
By:	/s/ David L. Stepp	By:	/s/ David L. Stepp
	Name:	David L. Stepp	Name:	David L. Stepp
	Its:	Authorized Signatory	Its:	Authorized Signatory
VHCP Management II, LLC		VHCP Management III, LLC
By:	/s/ David L. Stepp	By:	/s/ David L. Stepp
	Name:	David L. Stepp	Name:	David L. Stepp
	Its:	Authorized Signatory	Its:	Authorized Signatory
Nimish Shah		Bong Koh
By:	/s/ David L. Stepp	By:	/s/ David L. Stepp
	David L. Stepp, as attorney-in-fact		David L. Stepp, as attorney-in-fact

Field: Page; Sequence: 13; Value: 2

13

Field: /Page

CUSIP No. 75955J402

EXHIBITS

A:	Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on December 16, 2019)
B:	Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed on December 16, 2019)
C:	Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on December 16, 2019)

Field: Page; Sequence: 14; Options: Last

14

Field: /Page